Neuromodulators and fillers, available in the city.
Unlike surgery, injectable appointments take place at the Sutton Place Manhattan office directly. No travel to Syracuse is required. Botox and dermal fillers are offered in New York City as part of the same practice that performs facelift, rhinoplasty, and blepharoplasty.
The most meaningful distinction between injectables and surgery at Natural Face Clinic is geographic: surgical procedures require a visit to the practice's accredited surgical suite in Syracuse. Injectable treatments do not. Neuromodulators and dermal fillers are available at the Sutton Place Manhattan office, at 347 E 53rd St, Suite Lobby A. Manhattan patients seeking Botox or filler with a surgeon rather than a mid-level provider can access that without traveling outside the city.
The 6 train stops at 51st Street, one block from the office. The E and M trains serve Lexington Avenue/53rd Street. Call or text 929-291-0922 to schedule an injectable appointment. The consultation and treatment often take place at the same visit for patients who have already been evaluated and whose treatment plan is established.
Dr. Kim is double board-certified in otolaryngology and facial plastic and reconstructive surgery -- two separate boards, not one. That training pathway, which began with the deep structural anatomy of the head and neck, is relevant to injectable work: the vascular anatomy of the face, the fascial planes, and the distribution of the facial nerve are not incidentally learned alongside cosmetic procedure technique. They are the foundation of a surgical training that injectable treatment draws on directly.
The practice limits injectable treatment to the face and neck -- the same anatomic territory as the surgical work. There are no body contouring injectables, no foot treatments, and no unrelated cosmetic services. The concentration means every injectable decision -- which plane, which product, which dose -- is made by a physician whose entire clinical attention is on the face and the structures beneath it.
Injectable appointments at the Manhattan office are appropriate for patients who want neuromodulators or fillers as a standalone treatment, for surgical patients who have completed their recovery and are considering complementary injectable maintenance, and for patients who are evaluating surgery and want to understand what injectables can and cannot do before making that decision. The distinction between what injectables address and what surgery addresses is discussed plainly at the appointment.
For a detailed account of the products, techniques, and considerations involved, see our full injectable dermal fillers overview.
A neuromodulator -- the category that includes Botox, Dysport, Xeomin, and Daxxify -- works at the junction between a nerve and a muscle. By interrupting the signal that tells the muscle to contract, it reduces the force of that contraction. The lines and creases addressed by neuromodulators are dynamic lines -- ones created by movement, not present at rest. The vertical lines between the brows that appear when frowning, the horizontal lines across the forehead from raising the brows, and the crow's feet at the outer corners of the eyes are the most common areas treated. Neuromodulator effect begins within a few days and typically reaches its full result at two weeks; the effect reverses over three to four months as the nerve-muscle connection is restored.
A dermal filler works through an entirely different mechanism: it adds physical material to a tissue plane. The loss of volume in the midface, the hollowing of the tear trough, the thinning of the lips, and the loss of definition along the jawline are primarily volume problems; a filler addresses them by restoring the volume that has been lost or by supporting a structural plane that has descended.
The distinction matters because patients sometimes arrive expecting one to do the other's job. Neuromodulators cannot restore volume; they can only reduce the muscle activity that creates dynamic lines. Fillers cannot soften a dynamic line the way neuromodulators can; they can add volume around it but cannot stop the muscle from creating the crease. A nasolabial fold that is deep because it is a volume transition zone responds differently to treatment than a crow's foot that is a movement line. The consultation examines the anatomy and determines which mechanism is relevant to each concern.
Many patients benefit from both at the same appointment. The two treatments do not interfere with each other and are safely combined. When surgery is also part of the picture, the timing of injectables relative to a surgical procedure is discussed at the consultation -- not all combinations or sequences are advisable, and the order matters.
Vascular occlusion is the most serious complication of dermal filler injection. It occurs when filler material enters or compresses a blood vessel, interrupting blood supply to the tissue downstream. The consequences range from skin blanching and, if not caught immediately, to tissue necrosis (skin death), to, in rare cases involving the ophthalmic or central retinal artery, permanent vision loss or stroke. These outcomes have been reported with every filler product, every injection technique, and injectors at every experience level. They cannot be entirely eliminated; they can only be minimized by technique and managed quickly when they occur.
At this practice, several precautions are standard. The vascular anatomy of the face -- where the named arteries run, where their branches approach the surface, and which territories overlap -- is part of the clinical decision for every injection placement. The choice between a needle and a blunt-tipped cannula, and which size, is made with that anatomy in mind. Aspiration before injection in high-risk areas is practiced where clinically appropriate, with the recognition that aspiration is not fully reliable for detecting intravascular placement.
After treatment: any new vision change, any sudden severe pain in a treated area, or any change in skin color -- blanching, a livedo pattern, or early discoloration -- is treated as a medical emergency. The appropriate response is the nearest emergency department, not a call to the office. This is stated plainly at every appointment where filler is placed. Hyaluronidase to dissolve hyaluronic acid filler is kept on-site; dissolving the product is part of the initial management of a suspected occlusion, not something that waits for a scheduled appointment.
Product selection is a clinical decision based on the anatomy, not a brand preference.
| Category | Mechanism | Typical duration | When appropriate |
|---|---|---|---|
| Neuromodulators | Reduces muscle contraction at the nerve-muscle junction | 3-4 months | Dynamic lines from muscle movement; brow shaping; platysmal banding in the neck |
| Soft HA fillers | Adds volume to superficial planes in mobile or thin-skinned areas | 6-12 months | Lips, perioral lines, fine lines in thin skin |
| Firm HA fillers | Provides structural support in deeper planes | 12-18 months | Midface volume, cheek structure, tear trough, jawline definition |
| Biostimulatory fillers | Stimulates the patient's own collagen production over months | 18-24 months or longer | Global facial volume loss; patients preferring gradual, diffuse improvement |
The following reflects common experience; individual appointments vary based on scope and patient factors.
A brief assessment at the start of the appointment confirms the treatment plan discussed at consultation. Photographs are taken before product is placed. Topical numbing cream is applied before filler treatment and allowed to take effect; most neuromodulator appointments do not require topical numbing. Prior filler history and any new medications or supplements since the last appointment are reviewed.
Injection appointments are typically 30 to 60 minutes in total. Small bumps from filler at the injection site resolve within minutes to hours. Bruising, when it occurs, is most common near the lips and the tear trough. Ice is applied to reduce swelling. Patients are given written post-care instructions and the office number before leaving. Most patients return to their normal schedule the same day.
A follow-up appointment is scheduled two to four weeks after any injectable treatment. For neuromodulators, this allows assessment of the result and, if indicated, a small touch-up to areas that responded less completely. For fillers, it allows the treating physician to see the settled result and confirm that no correction is needed. Follow-up is not optional; it is part of the standard treatment protocol.
Yes. Neuromodulators and dermal fillers are offered at the Sutton Place Manhattan office and do not require travel to Syracuse. This distinguishes injectables from surgical procedures -- facelift, rhinoplasty, and blepharoplasty all require a trip to the accredited Syracuse surgical suite. Injectable appointments take place entirely in New York City.
Neuromodulators offered include the major FDA-approved products used to soften dynamic lines -- the creases created by muscle movement at the brow, forehead, and periorbital area. Dermal fillers include hyaluronic acid products in a range of viscosities for different tissue planes and anatomic regions, along with biostimulatory options for patients seeking gradual collagen stimulation. Product selection is discussed at the appointment based on the anatomy and the goals, not chosen from a menu in advance.
A neuromodulator acts on the nerve-muscle junction, reducing the strength of muscle contraction in the treated area. This softens the lines and creases that form from repeated movement -- the vertical lines between the brows, the horizontal forehead lines, the crow's feet at the outer corners of the eyes. A dermal filler adds physical volume to a tissue plane. It restores lost fullness, defines a contour, or fills a hollow. The two products work through entirely different mechanisms and are not interchangeable; some patients benefit from one, some from the other, and some from both at the same appointment.
The selection depends on three things: the tissue plane being treated, the mechanical properties required of the product in that plane, and the anatomy of the individual patient. Soft, low-viscosity hyaluronic acid products are appropriate for superficial planes in thin-skinned areas; firmer, more cross-linked products are appropriate for deep structural support. Injecting a product into the wrong plane for its viscosity produces visible lumps, unnatural stiffness, or the blue discoloration called the Tyndall effect. The choice of product and placement is a clinical decision, not a product-preference one.
Vascular occlusion occurs when filler is injected into or compresses a blood vessel, interrupting blood flow to the tissue it supplies. In the face, this can cause tissue necrosis -- death of the skin -- and in rare cases involving the ophthalmic or central retinal artery, vision loss or stroke. It is the most serious risk of dermal filler injection and has been reported with every product type and every injector. Management begins before treatment: careful anatomic knowledge of the vascular territory, aspiration technique when appropriate, and use of a blunt cannula in high-risk areas where the technique is appropriate. After treatment, any new change in vision, severe pain, or skin color change is treated as an emergency requiring immediate evaluation at an emergency department -- not a call to the office.
The appointment begins with an assessment of the anatomy and a review of the goals. Photographs are taken. The treatment plan is discussed before any product is drawn -- what areas, which products, and in what amounts. Most injectable appointments take between 30 and 60 minutes depending on the scope. Topical numbing is applied before filler treatment; neuromodulator injections typically do not require it. A follow-up appointment is scheduled two to four weeks afterward to assess the result.
Neuromodulators typically last three to four months, though duration varies by individual metabolism, the muscle treated, and the dose. Dermal fillers vary considerably by product: softer hyaluronic acid fillers in mobile areas may begin to resorb within six to nine months; firmer products in structural areas often last 12 to 18 months or longer. Biostimulatory fillers produce a gradual response over months and the result develops slowly. Longevity claims in product marketing represent averages from controlled trials, not guarantees for individual patients.
In some situations, yes; in others, no -- and the distinction matters. Neuromodulators address dynamic lines created by muscle movement; surgery cannot replicate that effect, and injectables cannot replicate the structural correction of a facelift or rhinoplasty. Volume replacement with filler can postpone or reduce the scope of surgical correction in some patients, but it does not address the underlying structural descent that surgery corrects. For some patients, injectables are the right and complete answer; for others, they mask a problem that surgery would address more durably. That discussion belongs in the consultation, where the anatomy can actually be assessed.
Subcision is a technique in which a needle or cannula is used beneath the skin surface to release fibrous tethering bands that create fixed or bound-down scars and certain types of acne scarring. The release allows the overlying skin to lift slightly and, when combined with filler or fat transfer, the treated area to improve. It is not a filler technique and not a standard injectable appointment; it is a separate procedure that may be offered when bound-down scarring is part of the picture and conservative treatment has been discussed.
For neuromodulators, most patients have no meaningful downtime; small injection marks resolve within hours and bruising is uncommon. For fillers, bruising is more common -- approximately 20 to 30 percent of patients experience some bruising, particularly around the lips and tear trough. Swelling is expected for one to three days after filler, longer in the lips. Most patients are comfortable returning to normal activity the same day; returning to a public setting the same day is possible but bruising is visible when it occurs.
Yes. Filler that has not fully resorbed from a prior treatment occupies tissue planes and changes the feel and appearance of the anatomy. At the assessment, prior filler history -- what product, where, and when -- is discussed. When there is uncertainty about what product was used or how much remains, conservative treatment is the standard approach: adding product on top of prior filler without knowing what is there and in what quantity carries more risk than treating a fresh anatomy.
Yes. Hyaluronic acid fillers can be dissolved with hyaluronidase, an enzyme that breaks down the hyaluronic acid chain. Dissolution is used to correct overfill, product in the wrong plane, asymmetry, or vascular occlusion. The enzyme works quickly -- within hours -- but the treated area may swell temporarily. Not all fillers are hyaluronic acid; biostimulatory products such as calcium hydroxylapatite or poly-L-lactic acid are not reversible with hyaluronidase.
The Manhattan office in Sutton Place offers injectable appointments without travel requirements. Surgical consultations are also available there. The accredited Syracuse surgical suite is where operative procedures take place. The Rochester office serves Central New York patients separately.
347 E 53rd St, Suite Lobby A
New York, NY 10022
929-291-0922
Injectables, consultations & follow-up
4939 Brittonfield Pkwy, Bldg B, Ste 208
East Syracuse, NY 13057
315-471-8404
Surgery & primary care
Serving the Greater Rochester area
315-471-8404
Consultations and follow-up
"I had fillers with him at the Manhattan office -- no trip to Syracuse necessary for this. He explained every product choice and why he was placing it where he was. I left understanding the treatment, not just having had it done."
"He was direct about what filler could and could not do for me. I appreciated that he spent more time explaining what I didn't need than selling me on it. Follow-up was at the Manhattan office two weeks later, just as promised."
"The consultation for my surgical work was there and he also addressed my filler questions at the same visit. It was efficient and thorough -- I felt like I was working with someone who had a clear plan rather than a menu."
As seen in